BioSyent, Inc. (BIOYF)
8.776
0.00 (0.00%)
USD |
OTCM |
Dec 12, 16:00
BioSyent EPS Diluted (Quarterly): 0.1693 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.948M |
| Revenue (Quarterly) | 8.874M |
| Total Expenses (Quarterly) | 6.926M |
| Enterprise Value | 82.66M |
| Gross Profit Margin (Quarterly) | 74.17% |
| Profit Margin (Quarterly) | 21.95% |
| Earnings Yield | 6.14% |
| Operating Earnings Yield | 7.73% |
| Normalized Earnings Yield | 6.138 |